Oxetanes
Medchemexpress LLC Vu0238441 | 85511-68-8 | 99.9% | 10 MG
VU0238441 is a pan muscarinic acetylcholine receptor (mAChR) positive allosteric modulator used as a research tool to potentiate M1-M5 receptor responses in pharmacology and neuroscience studies.
- Potentiates M1-M5 receptor responses; EC50s: M1 3.2 μM, M2 2.8 μM, M3 2.2 μM, M5 2.1 μM, M4 >10 μM.
- High purity (99.9%).
- Molecular formula C16H9ClF3NO2; molecular weight 339.70 g·mol⁻¹.
- Available as powder and as a 10 mM solution in DMSO; common pack sizes from 5 mg to 500 mg.
- For research use only; not for human or clinical applications.
![Advanced Chemblocks Inc 2-Oxa-6-aza-spiro[3.3]heptane; 1G; 97%](https://assets.fishersci.com/TFS-Assets/CCG/product-images/VN00120763-A-799.PNG-250.jpg)
Advanced Chemblocks Inc 2-Oxa-6-aza-spiro[3.3]heptane; 1G; 97%
Chemical Name: 2-Oxa-6-aza-spiro[3.3]heptane CAS: 174-78-7 MW: 99.13 MDL Number: MFCD12407093 Category: spiro Synonym: 2-Oxa-6-aza-spiro[3.3]heptane
eMolecules 864373-47-7 | oxetane-2-carboxylic acid | Pharmablock | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 25mg | 551170777
oxetane-2-carboxylic acid | Pharmablock | 864373-47-7 | MFCD08544406 | 102.089 | C4H6O3 | 97.000 | OC(=O)C1CCO1 | 25mg | 551170777
eMolecules 114012-41-8 | OXETANE-3-CARBOXYLIC ACID | AstaTech | MFCD08669505 | 102.089 | C4H6O3 | 95.000 | OC(=O)C1COC1 | 5g | 213336222
OXETANE-3-CARBOXYLIC ACID | AstaTech | 114012-41-8 | MFCD08669505 | 102.089 | C4H6O3 | 95.000 | OC(=O)C1COC1 | 5g | 213336222
![eMolecules 2241107-29-7 | (S)-Oxetane-2-carboxylic acid | ChemScene102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 632321292](https://assets.fishersci.com/TFS-Assets/CCG/product-images/default.jpg-250.jpg)
eMolecules 2241107-29-7 | (S)-Oxetane-2-carboxylic acid | ChemScene102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 632321292
(S)-Oxetane-2-carboxylic acid | ChemScene | 2241107-29-7102.089 | C4H6O3 | 97.000 | OC(=O)[C@@H]1CCO1 | 1g | 632321292
eMolecules 1305207-52-6 | Oxetane-3-carbaldehyde | Advanced ChemBlocks - In Stock | MFCD21604173 | 86.090 | C4H6O2 | 97.000 | O=CC1COC1 | 250mg | 381427173
Oxetane-3-carbaldehyde | Advanced ChemBlocks - In Stock | 1305207-52-6 | MFCD21604173 | 86.090 | C4H6O2 | 97.000 | O=CC1COC1 | 250mg | 381427173
eMolecules 1396215-84-1 | Oxetane-3-boronic Acid Pinacol Ester | Accela ChemBio (ASD) | MFCD26521383 | 184.040 | C9H17BO3 | 97.000 | CC1(C)OB(OC1(C)C)C1COC1 | 1g | 553164233
Oxetane-3-boronic Acid Pinacol Ester | Accela ChemBio (ASD) | 1396215-84-1 | MFCD26521383 | 184.040 | C9H17BO3 | 97.000 | CC1(C)OB(OC1(C)C)C1COC1 | 1g | 553164233
Medchemexpress LLC RBN-3143 | 2360853-16-1 | C22H28FN3O4S | 100 MG
RBN-3143 is a potent and selective inhibitor targeting PARP14, exhibiting an IC50 value of 4 nM. This compound effectively inhibits PARP14-mediated ADP-ribosylation and helps stabilize PARP14 in cellular models. It has shown promise in preclinical studies related to lung inflammation.
- Potent and NAD+-competitive PARP14 inhibitor.
- Demonstrates an IC50 of 4 nM against PARP14.
- Inhibits ADP-ribosylation activity of PARP14.
- Stabilizes PARP14 in cell lines.
- Investigated for its potential in lung inflammation research.
eMolecules 1065075-83-3 | TERT-BUTYL 3-(ALLYLOXY)-3-VINYLPIPERIDINE-1-CARBOXYLATE | AstaTech | MFCD11100937 | 267.369 | C15H25NO3 | 95.000 | CC(C)(C)OC(=O)N1CCCC(C1)(OCC=C)C=C | 1g | 112531733
TERT-BUTYL 3-(ALLYLOXY)-3-VINYLPIPERIDINE-1-CARBOXYLATE | AstaTech | 1065075-83-3 | MFCD11100937 | 267.369 | C15H25NO3 | 95.000 | CC(C)(C)OC(=O)N1CCCC(C1)(OCC=C)C=C | 1g | 112531733
eMolecules 1638760-80-1 | METHYL OXETANE-3-CARBOXYLATE | AstaTech | MFCD22566365 | 116.116 | C5H8O3 | 95.000 | COC(=O)C1COC1 | 0.25g | 206684069
METHYL OXETANE-3-CARBOXYLATE | AstaTech | 1638760-80-1 | MFCD22566365 | 116.116 | C5H8O3 | 95.000 | COC(=O)C1COC1 | 0.25g | 206684069
eMolecules 26272-85-5 | 3-Iodooxetane | Oakwood Chemicals | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 5g | 480164357
3-Iodooxetane | Oakwood Chemicals | 26272-85-5 | MFCD08544403 | 183.976 | C3H5IO | 98.000 | IC1COC1 | 5g | 480164357
eMolecules 39267-79-3 | 3-Bromooxetane | Accela ChemBio | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 5g | 784390703
3-Bromooxetane | Accela ChemBio | 39267-79-3 | MFCD08544402 | 136.976 | C3H5BrO | 97.000 | BrC1COC1 | 5g | 784390703
Medchemexpress LLC Rbn-3143 | 2360853-16-1 | 99.3% | 449.54 g/mol | C22H28FN3O4S | 10 MG
RBN-3143 is a small-molecule, NAD+-competitive catalytic inhibitor of PARP14 with reported nanomolar potency (IC50 ≈ 4 nM). It inhibits PARP14-mediated ADP-ribosylation, stabilizes PARP14 in cell lines, and is provided for research use to support studies of PARP14 biology and inflammatory disease models.
- NAD+-competitive catalytic inhibitor of PARP14.
- Reported IC50 ≈ 4 nM against PARP14.
- Inhibits PARP14-mediated ADP-ribosylation in cell assays.
- Stabilizes PARP14 protein in cell lines.
- High reported chemical purity (~99.3%).
- Available in multiple research pack sizes for laboratory studies.
eMolecules 21635-88-1 | 3-Aminooxetane | Apollo Scientific | MFCD08544363 | 73.095 | C3H7NO | 97.000 | NC1COC1 | 1g | 600856170
3-Aminooxetane | Apollo Scientific | 21635-88-1 | MFCD08544363 | 73.095 | C3H7NO | 97.000 | NC1COC1 | 1g | 600856170
eMolecules 1305207-52-6 | 3-oxetane-carboxaldehyde | Synthonix | MFCD21604173 | 86.090 | C4H6O2 | 90.000 | O=CC1COC1 | 1g | 722006485
3-oxetane-carboxaldehyde | Synthonix | 1305207-52-6 | MFCD21604173 | 86.090 | C4H6O2 | 90.000 | O=CC1COC1 | 1g | 722006485